28 julio 2015
Exogenous glucagon-like peptide 2 (GLP-2) treatment may help fight neonatal parenteral nutrition associated liver disease (PNALD), a new study suggests.img src=»http://feeds.feedburner.com/~r/sciencedaily/~4/Syj9YTCRV54″ height=»1″ width=»1″ alt=»»/
http://feeds.sciencedaily.com/~r/sciencedaily/~3/Syj9YTCRV54/150728091734.htm
